AUSTIN, Texas, June 26, 2018 (GLOBE NEWSWIRE) — Pain Therapeutics, Inc. (Nasdaq:PTIE), a drug development company, today announced that a joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk…Original Article
Pain Therapeutics Announces Results of FDA Advisory Committee Meeting for Remoxy ER
